December 18, 2014
Nordic Nanovector: - Nordic Nanovector ASA – Financial Calendar 2015
(Press Release 41/2014). See link for details

December 17, 2014
Nordic Nanovector: - Nordic Nanovector ASA – Registered share capital increase
(Press Release 40/2014). See link for details

December 15, 2014
Nordic Nanovector: - Nordic Nanovector ASA – Registered share capital increase
(Press Release 39/2014). See link for details

December 11, 2014
Nordic Nanovector: - Nordic Nanovector to Present at DNB Markets 5th Annual Health Care Conference Today
(Press Release 38/2014). See link for details
See: Presentation DNB Health Care Conference

December 10, 2014
Nordic Nanovector: - Nordic Nanovector Patent Granted in Japan
(Press Release 37/2014). See link for details

December 8, 2014
Nordic Nanovector: - Nordic Nanovector presented phase I study data reporting promising clinical activity in patients with relapsed non-Hodgkin lymphoma at ASH
(Press Release 36/2014). See link for details

December 2, 2014
Nordic Nanovector: - Nordic Nanovector To Present Clinical Data from Phase I/II Trial on Betalutin™ at Upcoming American Society of Hematology (ASH) Meeting
(Press Release 35/2014). See link for details

November 27, 2014
Nordic Nanovector: - Nordic Nanovector and Affibody collaborate on advanced radio-immunotherapies program for Multiple Myeloma
(Press Release 34/2014). See link for details

November 12, 2014
Nordic Nanovector: - Extraordinary General Meeting held in Nordic Nanovector ASA
(Press Release 33/2014). See link for details
See: Minutes from EGM November 12 2014

November 4, 2014
Nordic Nanovector: - NORDIC NANOVECTOR AS: EXTRAORDINARY GENERAL MEETING ON 12 NOVEMBER 2014
(Press Release 32/2014). See link for details
See: Nordic Nanovector Notice of EGM including appendix

November 3, 2014
Nordic Nanovector: - Nordic Nanovector strengthens management team to prepare for its next phase
(Press Release 31/2014). See link for details

October 28, 2014
Nordic Nanovector: - Nordic Nanovector AS – Registered share capital increase
(Press Release 30/2014). See link for details

October 24, 2014
Nordic Nanovector: - Nordic Nanovector AS: Issuance of shares to HealthCap VI L.P
(Press Release 29/2014). See link for details

October 23, 2014
Nordic Nanovector: - Nordic Nanovector AS: Third quarter report 2014
(Press Release 28/2014). See link for details
See: Third Quarter Report 2014

September 22, 2014
Nordic Nanovector: – Registered share capital increase
(Press Release 27/2014). See link for details.

September 16, 2014
Nordic Nanovector: – Final result of the subsequent offering
(Press Release 26/2014). See link for details.

September 15, 2014
Nordic Nanovector: – Preliminary result of the subsequent offering
(Press Release 25/2014). See link for details.

September 1, 2014
Nordic Nanovector: – Subsequent Offering
(Press Release 24/2014). See link for details.

August 29, 2014
Nordic Nanovector: – Approved prospectus
(Press Release 23/2014). See link for details.

August 26, 2014
Nordic Nanovector: Second Quarter Report 2014

(Press Release 22/2014). See link for details.
See: Second Quarter Report 2014  

August 26, 2014
Nordic Nanovector: The Board appoints Mr. Luigi Costa as new CEO
(Press Release 21/2014). See link for details.

July 7, 2014
Nordic Nanovector: Listing on NOTC
(Press Release 20/2014). See link for details.

July 1, 2014
Nordic Nanovector AS: Change in the Board
(Press Release 19/2014). See link for details.

June 27, 2014
Extraordinary General Meeting held in Nordic Nanovector AS
(Press Release 18/2014). See link for details. 
See Minutes of Extraordinary General Meeting

June 19, 2014
Extraordinary General Meeting in Nordic Nanovector
(Press Release 17/2014). See link for details. 
See Notice of Extraordinary General Meeting

June 18, 2014
Nordic announces successful closing of NOK 250 million pre-IPO private placement
(Press Release 16/2014). See link for details.

June 17, 2014
Nordic Nanovector – Status of bookbuilding and increase in size of the offering
(Press Release 15/2014). See link for details.

June 12, 2014
Nordic Nanovector – Status of bookbuilding
(Press Release 14/2014). See link for details.   

June 10, 2014
Betalutin™ granted Orphan Designation in Europe
(Press Release 13/2014). See link for details.

June 6, 2014
Nordic Nanovector intends to undertake private placement of NOK 150 million
(Press Release 12/2014). See link for details.

May 20, 2014
Betalutin™ granted Orphan-drug Designation in the USA
(Press Release 11/2014). See link for details

May 14, 2014

• First Quarter Report 2014 (Press Release 10/2014). See link for details.
• First Quarter Report 2014. See link for details.
• Annual General Meeting held today. (Press Release 09/2014). See link for details.
• Nordic Nanovector AS, AGM Presentation, 14 May. See link for details.

May 13, 2014
Conversion of MNOK 25 Convertible Loan.
(Press Release 08/2014). See link for details.

March 27, 2014
Betalutin™ successful completion of phase 1 part of phase 1/2 study

(Press Release 06/2014) See link for details.

March 27, 2014
Fourth Quarter and Full Year Report 2013

(Press Release 05/2014) See link for details.

March 19, 2014
Nordic Nanovector Patent Granted in Europe

(Press Release 04/2014) See link for details.

February 24, 2014
Extraordinary General Meeting held today
(Press Release 03/2014) See link for details.

February 24, 2014
Nordic Nanovector AS, EGM Presentation
See link for details.

February 14, 2014
Notice of Extraordinary General Meeting 
(Press Release 02/2014) See link for details.

January 15, 2014
Nordic Nanovector Patent Issues in USA 
(Press Release 01/2014, See link for details.